Optimising Skin Cancer Prevention: Cost-Effecti...

By Melike Belenli Gümüş

July 9, 2024

Introduction According to the Centers for Disease Control and Prevention (CDC), nearly 6 million people in the United States undergo treatment for skin cancer annually, with the incidence of new cases o...
Transferability of AI Methods for Diabetes Modelling in Health Technology Ass...
Innovative Funding Models for Non-Communicable Diseases
Fremanezumab: Cost-Effective Relief for Chronic Migraine
Enhancing Global Health through Cost-Effectiveness Analysis
The Role of Pull Incentives in Addressing Antimicrobial Resistance
A New Approach to Cardiovascular Risk Assessment for Statin Therapy
Cost-Effectiveness of IDegAsp in Diabetes Management: Insights from ARISE Study
Understanding the Cost and Clinical Impact of Multisystem Inflammatory Syndro...
Striking the Balance: Optimising Hepatitis B Treatment Strategies in The Gambia
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
Enhancing Surgical Recovery Predictions with AI: A New Approach
Cost Savings on Generic Drugs: Transparent Pricing Models